Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 study for MOB-015 against nail fungus.

GeekWire’s in-depth startup coverage tells the stories of the Pacific Northwest entrepreneurial scene. (Arzeda Photo) Arzeda, a protein design startup that generates new enzymes for industrial ...

MISSISSAUGA, ON, Sept. 13, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg ...

Former RayzeBio chief Ken Song, M.D., is at the helm of the biotech. 4. AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail ahead of FDA decision Detailed data from the TROPION-Lung01 ...

Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

The grant funding was announced on the margins of a two-day East Africa Pharma and Biotech conference in Rwanda’s capital Kigali. The funding is aimed at increasing equitable access to medicines ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry ... Is there a simple "7 step model" for buying? I'm not sure but let me see if I can create one!

As India cements its status as the "pharmacy of the world," its pharmaceutical giants are not just keeping pace—they're setting the pace. With the industry projected to leap from a value of $40 ...

The “Pharma Bro” is done bringing the ruckus over ... they’re like hidden in safes all around the world . . . I’m not stupid,” Shkreli bragged during one livestream, according to court ...

Japan’s top drugmaker, Takeda Pharmaceutical, has completed a purchase of a €75m medicines factory in Russia, as it begins to fulfil its aim of taking over the Russian market. Last year ...

But to Tucker, the very idea was “agonizing,” writes Attkisson in her new book, “Follow the Science: How Big Pharma Misleads, Obscures, and Prevails” (Harper, out Tuesday). Why?